Latest News

Latest News

News from the World Hepatitis Alliance

Catch up with our second webinar with FIND

18 Feb 2020 Chris Wingrove

Join Sonjelle Shilton, Deputy Head HCV Access at the Foundation for Innovative New Diagnostics (FIND), as she explores strategies to increase access...

World Hepatitis Alliance welcomes three new board members

6 Jan 2020 Lucy Ferrier

The World Hepatitis Alliance is delighted to welcome three new members to its executive board...

hepVoice December is out now

19 Dec 2019 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + Meet WHA's new board members; + WHO report: Ignoring the health of people in prisons now...

World Hepatitis Day 2019 Summary Report out now

18 Dec 2019 Lucy Ferrier

With photographs and details of World Hepatitis Alliance member activities, a summary of major commitments and announcements from national governments, and impressive impact statistics, the World Hepatitis Day 2019 Summary Report is designed to demonstrate the impact of World Hepatitis Day (WHD) and to provide inspiration to others planning WHD activities for 2020....

hepinion: 2019, a year to remember

16 Dec 2019 Lucy Ferrier

by Cary James, WHA CEO We have come to the end of another year and I believe it’s important that we take time to pause and briefly reflect on the...

Catch up on the FIND webinar on hepatitis C diagnostics

28 Nov 2019 Chris Wingrove

On Wednesday the 27th November we were joined by FIND for a webinar on the diagnositcs landscape of hepatitis C testing. If you missed the webinar...

hepVoice November is Out Now

20 Nov 2019 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + Global hepatology societies call for better hepatitis C testing and access to treatment; +...

hepinion: decentralisation and task shifting will accelerate the elimination of viral hepatitis

19 Nov 2019 Lucy Ferrier

We will not achieve the elimination of hepatitis C if we do not reach those most at-risk and most affected. The decentralisation of services will help us test, treat and cure marginalised and at-risk communities, wherever they are....

Nominate your candidate to stand for election as a WHA Regional Board Member.

7 Nov 2019 Isabel Bull

Nominations are open for candidates to stand for election as the World Hepatitis Alliance (WHA) Regional Board Members for the African (AFRO),...

hepVoice October is out now

21 Oct 2019 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: World Hepatitis Alliance welcomes 10 new members; Universal Health Coverage: what it means...

hepinion: global funders must join the fight for hepatitis elimination

16 Oct 2019 Lucy Ferrier

by Dr Philip Bruggman Earlier this month, the Global Fund met for its sixth replenishment meeting in Lyon, France, where it achieved its ambitious...

EVENT: Universal Health Coverage & HIV – The Potential Impact of Collaborative Innovations with Viral Hepatitis Elimination

1 Oct 2019 Lucy Ferrier

The World Hepatitis Alliance, in collaboration with ICE-HBV and partners, are organising a session at the Global Fund’s replenishment conference in Lyon on 8 October....

The World Hepatitis Alliance and UNITE partner to combat viral hepatitis

26 Sep 2019 Lucy Ferrier

LONDON, UNITED KINGDOM (September 26, 2019) The World Hepatitis Alliance (WHA) and UNITE, the global parliamentarians network to end HIV/AIDS, viral...

Universal Health Coverage: what it means for viral hepatitis

25 Sep 2019 Lucy Ferrier

- written by Cary James, World Hepatitis Alliance CEO On Monday 23rd September I attended the United Nations (UN) High Level Meeting on Universal...

WHA and UNITE host side meeting at the United Nations High-Level Meeting on UHC

19 Sep 2019 Chris Wingrove

Securing political leadership and innovative funding to achieve Universal Health Coverage. Where: UNAIDS New York office, 801 2nd Avenue/43rd St....

United Against Hepatitis- A Network for Hepatitis Free Society

12 Sep 2019 Isabel Bull

In 2016, 194 governments including that of India committed to eliminating viral hepatitis as a public health threat by 2030. In doing so, India has committed to diagnosing 30 per cent of people living with viral hepatitis by 2020 and 90 per cent of people by 2030....

World Hepatitis Alliance and IAPAC Announce Fast-Track Cities Partnership

9 Sep 2019 Lucy Ferrier

The World Hepatitis Alliance (WHA) and the International Association of Providers of AIDS Care (IAPAC) announced a new partnership today on the first day of the Fast-Track Cities 2019 conference in London....

hepinion: Exploring a pioneering catalytic funding mechanism for elimination in Uzbekistan

3 Sep 2019 Tash Priya

In Uzbekistan around 5,300 people die each year from liver disease and cancer related to hepatitis B or C. The tragedy is that almost all of these deaths are preventable. Uzbekistan, like many other low- to middle-income countries, faces a huge economic and social burden because of viral hepatitis. With no global funder present to help them to tackle the disease, new innovative models of financing need to be explored to make hepatitis elimination a reality....

PRIME® launch Practical Toolkit for Building a Successful Partnership with High-Risk Hepatitis C Patients.

29 Aug 2019 Lucy Ferrier

Leading healthcare education and research company PRIME® has launched a practical toolkit aimed at aligning patients and providers in the prevention and treatment of hepatitis C....

World Hepatitis Day special: hepVoice August is Out Now

27 Aug 2019 Lucy Ferrier

The August 2019 edition of hepVoice, the monthly e-magazine from the World Hepatitis Alliance....

Pages

News from infohep

Diabetes raises the risk of liver damage in people with HIV

21 Sep 2020 Keith Alcorn
Almost half of people with HIV with unexplained liver enzyme elevations or other abnormal liver markers had non-alcoholic steatohepatitis (NASH) and...

Models can help predict liver cancer in people cured of hepatitis C

17 Sep 2020 Liz Highleyman
Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving...

International registries provide more information about COVID-19 and liver disease

17 Sep 2020 Liz Highleyman
People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver...

Aldafermin reduces liver fat in phase 2 study

14 Sep 2020 Keith Alcorn
Aldafermin significantly reduced liver fat content and liver damage in a phase 2 study of a 24-week treatment course, Dr Stephen Harrison, Visiting...

Fatty liver disease affects one in four in Europe, study estimates

7 Sep 2020 Keith Alcorn
Non-alcoholic fatty liver disease affects one in four people in the general population in Europe and just over one in twenty people have advanced...

Stopping antivirals may offer a chance for a hepatitis B cure

6 Sep 2020 Liz Highleyman
Discontinuation of long-term nucleoside/nucleotide antiviral treatment for hepatitis B can allow some people to achieve a cure, according to a pair...

Immunotherapy combinations show promise for advanced liver cancer

2 Sep 2020 Liz Highleyman
Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer,...

Gilead immune modulator has modest effect on hepatitis B surface antigen

1 Sep 2020 Keith Alcorn
Selgantolimod, a toll-like receptor agonist designed to enhance immune responses to hepatitis B virus, showed only modest effects on hepatitis B...

Bulevirtide shows promise as maintenance therapy for hepatitis D

30 Aug 2020 Liz Highleyman
High-dose bulevirtide (Hepcludex) combined with pegylated interferon alfa-2a (Pegasys) or tenofovir disoproxil fumarate (TDF; Viread) led to...

JNJ-3989 achieves sustained reductions in hepatitis B surface antigen

29 Aug 2020 Keith Alcorn
Johnson & Johnson’s short interfering RNA treatment for hepatitis B resulted in sustained reductions in hepatitis B surface antigen when...